GSK to shift consumer media business by end of Feb.

Share this article:
GSK to shift consumer media business by end of Feb.
GSK to shift consumer media business by end of Feb.
GlaxoSmithKline should be finished transitioning the media planning and buying for its North American OTC business by the end of February, a spokesperson for the drugmaker said. The benefactor of the switch, WPP shop MediaCom, already handles buying and planning tasks for GSK's North American prescription-drug business.

Malesia Dunn, GSK director of communications, said the shift was simply a business decision to allow for greater efficiency.

Media for the OTC brands—which include Panadol, Aquafresh, Lucozade and Nicorette—had been split among MediaCom, Havas' MPG, Publicis' Optimedia and Campbell Mithun.

Notably, last year GSK moved all of its professional advertising business in the opposite direction, from WPP agencies to IPG ones, including Draftfcb Healthcare and Lowe Healthcare's Integrated Communications unit.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in News

Five things for Pharma Marketers to know: Friday, August 29

Five things for Pharma Marketers to know: Friday, ...

Takeda closes out a good-news, bad-news kind of week, AstraZeneca adds a new clinical trial for its experimental PD-1, and researchers link a funeral to the Ebola outbreak.

Amgen sends PCSK9 to FDA

Amgen sends PCSK9 to FDA

Evolocumab holds the FDA's first filed biologics license application for the class.

Consultants expect M&A tempo to continue

Consultants expect M&A tempo to continue

PwC anticipates that divestitures will fuel late-2014 deals, but notes that the noise around early deals and the financials don't fully match up.